Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acupuncture vs Medication for Depression, Anxiety and Sleep Disorders in China
NCT07552246Phase 4Recruiting
- Sponsor
- Duke Kunshan University
- Start
- Apr 2026
- Primary completion
- Jun 2027
- Countries
- 1
01
Overview
Phase 4, open-label trial in major depressive disorder (MDD), anxiety disorder and sleep disorder (2 arms), sponsored by Duke Kunshan University. Primary endpoints: Mean change in depression at 6 months, Mean change in anxiety at 6 months and 1 more. Started Apr 2026; status: recruiting.
02
Conditions
major depressive disorder (MDD)anxiety disordersleep disorder
Beyond the preview
Go deeper on NCT07552246.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07552246.